Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00PES
|
|||
Drug Name |
PMID27109571-Compound-5
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H20N2O2
|
|||
Canonical SMILES |
C1CCN(C1)CCC2=NC=C(C=C2)C=CCC(=O)O
|
|||
InChI |
1S/C15H20N2O2/c18-15(19)5-3-4-13-6-7-14(16-12-13)8-11-17-9-1-2-10-17/h3-4,6-7,12H,1-2,5,8-11H2,(H,18,19)/b4-3+
|
|||
InChIKey |
YAJGYOKZMAZQGT-ONEGZZNKSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid-binding protein (FABP) | Target Info | Inhibitor | [1] |
Target's Patent Info | Fatty acid-binding protein (FABP) | Target's Patent Info | [1] | |
BioCyc | Malate-aspartate shuttle | |||
L-kynurenine degradation | ||||
4-hydroxyproline degradation | ||||
KEGG Pathway | Alanine, aspartate and glutamate metabolism | |||
Cysteine and methionine metabolism | ||||
Arginine and proline metabolism | ||||
Tyrosine metabolism | ||||
Phenylalanine metabolism | ||||
Phenylalanine, tyrosine and tryptophan biosynthesis | ||||
Metabolic pathways | ||||
Biosynthesis of antibiotics | ||||
Carbon metabolism | ||||
2-Oxocarboxylic acid metabolism | ||||
Biosynthesis of amino acids | ||||
Fat digestion and absorption | ||||
Panther Pathway | Asparagine and aspartate biosynthesis | |||
Pathwhiz Pathway | Glutamate Metabolism | |||
Malate-Aspartate Shuttle | ||||
Urea Cycle | ||||
Reactome | Gluconeogenesis | |||
Amino acid synthesis and interconversion (transamination) | ||||
WikiPathways | Glycolysis and Gluconeogenesis | |||
Metabolism of amino acids and derivatives | ||||
Metabolism of carbohydrates | ||||
Alanine and aspartate metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.